{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:16:37Z","timestamp":1762492597688,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ijcha.2022.101062","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T18:46:04Z","timestamp":1653677164000},"page":"101062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT)"],"prefix":"10.1016","volume":"41","author":[{"given":"Michele","family":"Violano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Poller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Roselle","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"Scheinman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Heidecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcha.2022.101062_b0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcha.2022.101062_b0010","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/europace\/eus031","article-title":"The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands","volume":"14","author":"Hayashi","year":"2012","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ijcha.2022.101062_b0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/europace\/eup448","article-title":"High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening","volume":"12","author":"Haugaa","year":"2010","journal-title":"Europace."},{"issue":"11","key":"10.1016\/j.ijcha.2022.101062_b0020","doi-asserted-by":"crossref","first-page":"e0207100","DOI":"10.1371\/journal.pone.0207100","article-title":"Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation","volume":"13","author":"Danielsen","year":"2018","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.ijcha.2022.101062_b0025","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/europace\/euz337","article-title":"Prevalence and electrophysiological phenotype of rare SCN5A genetic variants identified in unexplained sudden cardiac arrest survivors","volume":"22","author":"Giudicessi","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.ijcha.2022.101062_b0030","unstructured":"C. Napolitano, S.G. Priori, R. Bloise, Catecholaminergic polymorphic ventricular tachycardia, In: M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K.W. Gripp, et al. (Eds.), GeneReviews((R)), Seattle, WA, 1993."},{"issue":"1","key":"10.1016\/j.ijcha.2022.101062_b0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hrthm.2020.10.010","article-title":"2020 APHRS\/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families","volume":"18","author":"Stiles","year":"2021","journal-title":"Heart Rhythm."},{"issue":"2","key":"10.1016\/j.ijcha.2022.101062_b0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1540-8167.2011.02188.x","article-title":"Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia","volume":"23","author":"Marjamaa","year":"2012","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"8","key":"10.1016\/j.ijcha.2022.101062_b0045","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"issue":"22","key":"10.1016\/j.ijcha.2022.101062_b0050","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcha.2022.101062_b0055","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210209","article-title":"Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death","volume":"41","author":"Zhong","year":"2021","journal-title":"Biosci. Rep."},{"issue":"5","key":"10.1016\/j.ijcha.2022.101062_b0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/CIRCULATIONAHA.105.601294","article-title":"SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene","volume":"114","author":"Poelzing","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcha.2022.101062_b0065","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4065\/79.11.1380","article-title":"Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner\/coroner\u2019s cases","volume":"79","author":"Tester","year":"2004","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcha.2022.101062_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2022.0219","article-title":"Outcomes of patients with catecholaminergic polymorphic ventricular tachycardia treated with beta-blockers","author":"Mazzanti","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"17","key":"10.1016\/j.ijcha.2022.101062_b0075","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2018.02.056","article-title":"Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator","volume":"71","author":"Chatzidou","year":"2018","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906722001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906722001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:12:37Z","timestamp":1762492357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906722001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":15,"alternative-id":["S2352906722001117"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2022.101062","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT)","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2022.101062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101062"}}